... disease) gene at the androgenreceptor in 1991 [1], followed by the Huntington’sdisease (HD) gene in 1993 [2], and the cloning of the spinocerebellar ataxia type 1 gene [3], the expandedpolyglutamine ... SCA1 pointing to serinekinase inhibition as a therapeutic strategy, and clini-cal success with the treatment of SBMA by leupro-relin, underscore the importance of analysis of huntingtin toxicity ... of the hall-marks of HD in humans, but not as much in mousemodels, is the striking loss of the striatum, and up to 30% of total brain mass, prior to death [31]. In the neurons that remain to...